Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III, Multicenter Randomized Controlled Study of Neo-adjuvant Chemotherapy Paclitaxel + Cisplatin Versus Surgery Alone for Stage IIA-IIIB Esophageal Squamous Cell Carcinoma

NCT02395705 is registered in ClinicalTrials.gov with Henan Cancer Hospital as lead sponsor.

NCT NCT02395705
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02395705 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III, Multicenter Randomized Controlled Study of Neo-adjuvant Chemotherapy Paclitaxel + Cisplatin Versus Surgery Alone for Stage IIA-IIIB Esophageal Squamous Cell Carcinoma
Lead sponsor
Henan Cancer Hospital
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2015
Completion date
October 31, 2022
Enrollment
528 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

esophageal neoplasm